NCT06487143View on ClinicalTrials.gov

Efficacy, Metabolism and BMD of the 3-month TP Compared to the 1-month TP in ICPP

PHASE4Not yet recruitingINTERVENTIONAL
Enrollment

134

Participants

Timeline

Start Date

July 1, 2024

Primary Completion Date

December 30, 2026

Study Completion Date

December 30, 2026

Conditions
Central Precocious Puberty
Interventions
DRUG

Triptorelin pamoate（15mg）

Triptorelin pamoate 15mg is administered via intramuscular injection once every three months.

DRUG

Triptorelin acetate （3.75mg）

Triptorelin acetate 3.75mg is administered via intramuscular injection once every four weeks.

Trial Locations (1)

510020

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University, Guangzhou

All Listed Sponsors
lead

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

OTHER

NCT06487143 - Efficacy, Metabolism and BMD of the 3-month TP Compared to the 1-month TP in ICPP | Biotech Hunter | Biotech Hunter